Last Updated

16 Jun 2015

Phase Ib Trial of MSP3 LSP in Children in Tanzania


This study will evaluate the safety of candidate malaria vaccine MSP3 in children aged 12-24 months in Tanzania in a highland area with low malaria transmission.

Principal Investigator


2007 Oct - 2008 Aug
Project Site